CSIMarket
 
Amgen Inc   (AMGN)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
   Industry Biotechnology & Drugs
   Sector  Healthcare
 
Price: $254.2100 $2.91 1.158%
Day's High: $255.73 Week Perf: 3.6 %
Day's Low: $ 251.78 30 Day Perf: 2.97 %
Volume (M): 2,513 52 Wk High: $ 276.69
Volume (M$): $ 638,855 52 Wk Avg: $238.74
Open: $251.78 52 Wk Low: $210.28



 Market Capitalization (Millions $) 147,696
 Shares Outstanding (Millions) 581
 Employees 23,400
 Revenues (TTM) (Millions $) -
 Net Income (TTM) (Millions $) 7,085
 Cash Flow (TTM) (Millions $) -1,575
 Capital Exp. (TTM) (Millions $) 632

Amgen Inc
Amgen Inc. Is a global biotechnology company that discovers, develops, manufactures, and markets human therapeutics based on advances in cellular and molecular biology. On July 15, 2002, Amgen acquired all of the outstanding common stock of Immunex Corporation (“Immunex”) for stock and cash valued at $17.8 billion in a transaction accounted for as a business combination. Immunex was a leading biotechnology company dedicated to developing immune system science to protect human health. The acquisition has enhanced Amgen’s strategic position within the biotechnology industry by strengthening and diversifying its (1) product base and product pipeline in key therapeutic areas, and (2) discovery research capabilities in proteins and antibodies.


   Company Address: One Amgen Center Drive Thousand Oaks 91320 CA
   Company Phone Number: 447-1000   Stock Exchange / Ticker: NASDAQ AMGN
   AMGN is expected to report next financial results on February 07, 2022.


Customers Net Income fell by AMGN's customers Net margin fell to 0 %

-4.89 %

4.31 %

• Customers Performance • Customers Expend. • Customers Efficiency • List of Customers


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
ABBV        3.81% 
BIIB        2.51% 
MRK        5.25% 
LLY        6.92% 
JNJ        3.55% 
BMY        3.24% 
• View Complete Report
   



Pfsweb Inc

Loss Despite Sales Growth

In the first quarter of 2021 earnings season Pfsweb Inc increased losses of $-0.11 per share compared to $-0.01 a year ago and increased losses from $-0.07 per share from the previous quarter.

Sales grew slightly by 1.66% to $77.97 millions from $76.70 millions in the same quarter a year ago and sequentially Sales fell by -26.64% from $106.29 millions.

Sangui Biotech International Inc

Sangui Biotech International Inc announced third quarter of 2021 earnings season operating loss of $-0.028325 millions

Sangui Biotech International Inc recorded operating shortfall of $-0.028325 millions, in the third quarter of 2021 earnings season, a progress from the operating shortfall of $-0.037455 millions, reported in third quarter of 2020

Sales increased sharply by 129.96% to $0.02 millions from $0.01 millions in the same quarter a year ago and sequentially Sales surged by 98.11 % from $0.01 millions.

Altex Industries Inc

Altex Industries Inc announced fiscal period ending Mar 31 2021 operating shortfall of $-0.05 millions

Altex Industries Inc recorded operating shortfall of $-0.05 millions, in the fiscal period ending Mar 31 2021, a degradation from the operating shortfall of $-0.041 millions, reported in second quarter of 2020

Sales fell sharply to $0.00 millions from $0.01 millions in the same quarter a year ago and sequentially from $0.01 millions.

Liveperson Inc

Company Fail to Break-even Despite Surge in Sales

Company lost money at $-0.31 per share in the most recent fiscal period, although its Sales surged by 38.17% to $107.89 millions from the same quarter a year ago.

In the previous quarter company realized Sales of $102.13 millions and $-0.20 per share.

Northern Oil And Gas Inc

Deficit Bigger Than a Year Ago, Topline Tumbles

Northern Oil And Gas Inc reported disastrous first quarter of 2021, where Sales faded by -95.78% to $21.40 millions and loss per share has widen to $-1.73, from the same quarter a year ago.

from the preceding quarter from $-3.29 per share, Sales Tumbled by -57.27% from $50.07 millions.






 

Amgen Inc 's Segments
 
United States
 Segment    80.22 % of total Revenue
International
 Segment    19.78 % of total Revenue
EPOGEN TM
 Segment    17.73 % of total Revenue
Aranesp
 Segment    8.94 % of total Revenue
Prolia
 Segment    11.6 % of total Revenue
NEUPOGEN
 Segment    5.15 % of total Revenue
Nplate
 Segment    2.48 % of total Revenue
Neulasta
 Segment    42.11 % of total Revenue
XGEVA
 Segment    6.85 % of total Revenue
ENBREL
 Segment    26.45 % of total Revenue
Vectibix
 Segment    0.98 % of total Revenue
 
• View Complete Report
  Company Estimates  
  Revenue Outlook
Amgen Inc does not provide revenue guidance.

Earnings Outlook
Northern Oil And Gas Inc does not provide earnings estimates.

 
Geographic Revenue Dispersion
United States 76.74 %
International 23.26 %


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

HSKA's Profile

Stock Price

HSKA's Financials

Business Description

Fundamentals

Charts & Quotes

HSKA's News

Suppliers

HSKA's Competitors

Customers & Markets

Economic Indicators

HSKA's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071